Rakhi Kumar

Rakhi Kumar

DirectoratRoivant Sciences· In proxies 2023–2025

Pay in FY2024+8% from the year before · Roivant Sciences stock +42.8% the same year

Rakhi Kumar was paid $4.7M in FY2024 (Mar), up 8%. Roivant Sciences stock rose 42.8% that year.

Pay$100 in the stock at the end of FY22 → $213
Pay is from the Summary Compensation Table of each Roivant Sciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NeuroPacePublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Roivant SciencesPublic company · 3 yr
    • Former Chief Accounting Officer2023 – Present · 3 yrStock in role +626%
  3. Roivant Social VenturesPublic company · 8 yr
    • Director2018 – Present · 8 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • NeuroPaceDirector · 4 yr on the boardIndependentAudit (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?